D’Angelo, S. ., Mahoney, M. ., Van Tine, B. ., Atkins, J. ., Milhem, M. ., Jahagirdar, B. ., … Streicher, H. . (2018). Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials. The Lancet. Oncology. https://doi.org/10.1016/S1470-2045(18)30006-8 (Original work published 2018)